Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

Counties on both sides of Guanella Pass are taking steps to prevent traffic gridlock from engulfing the popular leaf-peeper hotspot as fall foliage season beckons ...